Qube Research & Technologies LTD Biodesix Inc Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Biodesix Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 67,907 shares of BDSX stock, worth $20,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,907
Previous 145,791
53.42%
Holding current value
$20,372
Previous $218,000
80.73%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
51.1MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$2.48 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$1.83 Million0.07% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$1.72 Million3.25% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.27MShares$1.28 Million1.45% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.23 Million0.63% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $12M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...